Rare hepatic metastases of colorectal cancer in livers with symptomatic HBV and HCV hepatitis

Annali Italiani di Chirurgia

Volumn 84, Issue 3, 2013, Pages 323-327

  Li Destri, Giovanni ^a   Castaing, Marine ^a   Ferlito, Francesca ^a   Minutolo, Vincenzo ^a   Di Cataldo, Antonio ^a   Puleo, Stefano ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Colorectal cancer; Hepatitis chronic; Metachronous metastases; Pathogenesis

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; COLORECTAL CANCER, HEPATITIS CHRONIC, METACHRONOUS METASTASES, PATHOGENESIS.; COLORECTAL TUMOR; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

COLORECTAL CANCER, HEPATITIS CHRONIC, METACHRONOUS METASTASES, PATHOGENESIS.;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84893436685     PISSN: 0003469X     EISSN: 2239253X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Taylor I: Colorectal cancer and the liver. Ann R Coll Surg Engl, 1997; 79:315-18.
2. Seymour K, Charnley RM: Evidence that metastasis is less common in cirrhotic than in normal liver: A systematic review of postmortem case-control studies. Br J Surg, 1999; 86:1237-42.
3. Lieber MM: The rare occurrence of metastatic carcinoma in the cirrhotic liver. Am J Med Sci, 1957; 233:145-52.
4. Li Destri G, Rinzivillo C, Craxi G, La Greca G, Di Cataldo A, Puleo S, Licata A: Colorectal follow-up planning modified on the basis of our personal experience. Dig Surg, 1998; 15:64-68.
5. Li Destri G, Di Cataldo A, Puleo S: Colorectal cancer followup: useful or useless? Surg Oncol, 2006; 15:1-12.
6. Schemper M, Smith T: A note on quantifying follow-up in studies of failure time. Controlled clinical trials, 1996; 17:343-46.
7. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Statist Ass, 1958; 53:457-81.
8. Rothman KJ: Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chron Dis, 1978; 31:557-60.
9. Cox DR: Regression models and life-tables. J R Statist Soc, 1972; 34:187-220.
10. Lisa JR, Solomon C, Gordon EJ: Secondary carcinoma in cirrhosis of the liver. Am J Pathol, 1942; 18:137-40.
11. Uetsuji S, Yamamura M, Yamamichi K, Okuda Y, Takada H, Hioki K: Absence of colorectal cancer metastasis to the cirrhotic liver. Am J Surg, 1993; 166:176-77.
12. Utsunomiya T, Saitsu H, Saku M, Yoshida K, Matsumata T, Shimada M, Sugimachi K: Rare occurrence of colorectal cancer metastasis in livers infected with hepatitis B or C virus. Am J Surg, 1999; 177:279-81.
13. Song E, Chen J, Qingjia O, Fengxi S: Rare occurence of metastatic colorectal cancers in livers with replicative hepatitis B infection. Am J Surg, 2001; 181:529-33.
14. Gervaz P, Pak-art R, Nivatvongs S, Wolff BG, Larson D, Ringel S: Colorectal adenocarcinoma in cirrhotic patients. J Am Coll Surg, 2003; 196:874-79.
15. Iascone C, Ruperto M, Barillari P: Occurrence of synchronous colorectal cancer metastasis in the cirrhotic or fatty liver. Min Chir 2005; 60:185-90.
16. Qian HG, Zhang J, Leng JH, Zhou GQ, Wu JH, Tian XY, Yang Y, Hao CY: Association of hepatitis B virus infection and cirrhosis with liver metastasis in colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi, 2010; 13:202-04.
17. Qiu HB, Zhang LY, Zeng ZL, Wang ZQ, Luo HY, Keshari RP, Zhou ZW, Xu RH: HBV infection decreases risk of liver metastasis in patients with colorectal cancer: A cohort study. World J Gastroenterol, 2011; 17:804-08.
18. Vanbockrijck M, Kloppel G: Incidence and morphology of liver metastasis from extrahepatic malignancies to cirrhotic livers. Zentralbl Pathol, 1992; 138:91-96.
19. Utsunomiya T, Matsumata T: Metastatic carcinoma in the cirrhotic liver. Am J Surg, 1993; 166:776.
20. Okuno K, Hirai N, Lee YS, Kawai I, Shigeoka H, Yasutomi M: Involvment of liver-associated immunity in hepatic metastasis formation. J Surg Res, 1998; 75:148-52.
21. Ando K, Hiroshi K, Kaneko T, Moriyama T, Muto Y, Kayagabi N, Yagita H, Okumura K, Imawari M: Perforin, Fas/fas ligand, and TNF-alfa pathways as specific and bystander killing mechanism of hepatitis C visrus-specific human CTL. J Immunol, 1997; 158:5283-91.
22. Barsky SH, Gopalakrishna R: High metalloproteinase inhibitor content of human cirrhosis and its possible conference of metastasis resistance. J Natl Cancer Inst, 1988; 80:102-08.
23. Zeng Z, Sun Y, Shu W, Guillem JG: Tissue inhibitor of metalloproteinase- 3 is a basement menbrane associated protein that is significantly decreased in human colorectal cancer. Dis Col Rectum, 2001; 44:1290-96.